Clinical Trial Finds Psilocybin Eases Depression in Cancer Patients
Clinical trial results reveal that a single dose of psilocybin can significantly reduce depression and anxiety in cancer patients, with effects lasting up to two years. Larger studies are underway to confirm its therapeutic potential.
Recent clinical trial results have demonstrated that a single dose of psilocybin, a naturally occurring psychedelic compound found in certain mushrooms, can offer long-lasting relief from depression and anxiety for individuals battling cancer. The study, published in the journal Cancer, involved 28 patients diagnosed with cancer and major depressive disorder. Participants received psychological support before, during, and after administering a 25-mg dose of psilocybin.
Follow-up assessments conducted two years later revealed significant benefits: over half of the patients experienced substantial reductions in depression, with nearly half maintaining remission. Additionally, about 43% of patients showed decreased anxiety levels. The findings suggest that psilocybin can have enduring antidepressant effects following just a single dose.
An ongoing double-blind trial is now exploring whether up to two doses of psilocybin at 25 mg can further improve outcomes in depression and anxiety among cancer patients. This larger study aims to determine if repeated dosing can increase the rate of remission.
Lead researcher Dr. Manish Agrawal from Sunstone Therapies highlighted the potential of psilocybin, noting that it could become a valuable treatment option for depression in cancer patients if further studies confirm these promising results. The research builds on previous work indicating the long-term mental health benefits of psilocybin, and ongoing investigations may pave the way for its broader use in supportive cancer care.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Neuroscience Explains How Some Athletes Maintain Peak Performance as They Age
Discover how neuroscience reveals the secrets behind athletes' ability to stay sharp and perform at their best as they age, emphasizing brain plasticity and trainable resilience.
Enhancing Well-Being in Adults with ADHD by Embracing Personal Strengths: New Research Insights
New research reveals that recognizing and utilizing personal strengths significantly improves well-being and quality of life in adults with ADHD. Emphasizing positive traits like creativity and hyperfocus can empower individuals and support mental health interventions.
Significant Increase in Memory and Cognitive Challenges Among U.S. Adults, New Study Reports
A new study reveals a significant rise in memory and thinking problems among U.S. adults, particularly those under 40, highlighting urgent public health concerns and disparities.
Racial Discrimination Increases the Risk of Psychotic Symptoms
A comprehensive review reveals that racial and ethnic discrimination significantly increases the risk of developing psychotic symptoms, highlighting the vital need for societal reforms to address mental health disparities among minority groups.